Anti-phage serum antibody responses and the outcome of phage therapy

Area of Science:

• Microbiology
• Immunology
• Otolaryngology

Background:

• Phage therapy (PT) is an alternative treatment for bacterial infections.
• The role of serum anti-phage antibodies in predicting PT outcomes is unclear.
• Chronic sinusitis is a condition often treated with antibiotics, with phage therapy being explored as an alternative.

Purpose of the Study:

• To investigate the relationship between serum anti-phage antibody levels and the efficacy of phage therapy in patients with chronic sinusitis.
• To determine if pre-existing antibody levels or the development of antibodies during treatment correlate with treatment success.

Main Methods:

• Serum samples were collected from 25 patients with chronic sinusitis undergoing phage therapy.
• Anti-phage antibody levels were measured in these patients.
• Treatment outcomes were assessed and correlated with antibody levels.

Main Results:

• Approximately 30% of patients with weak antibody responses showed positive outcomes with PT.
• Treatment results in patients with weak antibody responses were comparable to those with high antibody production.
• No significant correlation was found between the level of serum anti-phage antibodies and the success of phage therapy.

Conclusions:

• Serum anti-phage antibody levels do not appear to be a reliable prognostic indicator for the outcome of phage therapy in chronic sinusitis.
• Further clinical trials are necessary to definitively establish the prognostic significance of serum anti-phage antibodies in phage therapy.
• These findings suggest that factors other than antibody levels may be more critical for predicting phage therapy success.